Tilak Mandadi

CIK: 0001872827

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (11.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)5 (55.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CVS

CVS HEALTH Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

CVS
CVS HEALTH Corp
May 8, 2026
Sale(S)
Direct
69.6K shares at avg. $89.58$6.2M
CVS
CVS HEALTH Corp
Apr 1, 2026
Tax Payment(F)
Direct
3.6K shares at avg. $72.49$263K
CVS
CVS HEALTH Corp
Mar 31, 2026
Award(A)
Direct
22.3K shares at avg. $71.82$1.6M
CVS
CVS HEALTH Corp
Nov 30, 2025
Tax Payment(F)
Direct
6.6K shares at avg. $80.36$528K
CVS
CVS HEALTH Corp
Aug 31, 2025
Tax Payment(F)
Direct
12.8K shares at avg. $73.15$939K
CVS
CVS HEALTH Corp
Apr 1, 2025
Award(A)
Direct
20.6K shares at avg. $67.98$1.4M
CVS
CVS HEALTH Corp
Apr 1, 2025
Tax Payment(F)
Direct
995 shares at avg. $67.98$68K
CVS
CVS HEALTH Corp
Nov 30, 2024
Award(A)
Direct
50.1K shares at avg. $59.85$3.0M
CVS
CVS HEALTH Corp
Aug 31, 2024
Tax Payment(F)
Direct
13.1K shares at avg. $57.24$750K

		Type	Shares	Price		Ownership
May 8, 2026	CVS CVS HEALTH Corp	Sale(S)	69,551	$89.58	$6,230,379	Direct
Apr 1, 2026	CVS CVS HEALTH Corp	Tax Payment(F)	3,634	$72.49	$263,429	Direct
Mar 31, 2026	CVS CVS HEALTH Corp	Award(A)	22,277	$71.82	$1,599,934	Direct
Nov 30, 2025	CVS CVS HEALTH Corp	Tax Payment(F)	6,575	$80.36	$528,367	Direct
Aug 31, 2025	CVS CVS HEALTH Corp	Tax Payment(F)	12,834	$73.15	$938,807	Direct
Apr 1, 2025	CVS CVS HEALTH Corp	Award(A)	20,594	$67.98	$1,399,980	Direct
Apr 1, 2025	CVS CVS HEALTH Corp	Tax Payment(F)	995	$67.98	$67,640	Direct
Nov 30, 2024	CVS CVS HEALTH Corp	Award(A)	50,125	$59.85	$2,999,981	Direct
Aug 31, 2024	CVS CVS HEALTH Corp	Tax Payment(F)	13,097	$57.24	$749,672	Direct

1-9 of 9 transactions

About Mandadi Tilak

Mandadi Tilak (SEC CIK 0001872827) files insider reports with the SEC as EVP, Chief Exp & Tech Officer of CVS HEALTH Corp (CVS).

Signal8 holds 7 ownership filings by Mandadi Tilak, all Form 4s, filed between Sep 3, 2024 and May 11, 2026. Those filings report 9 transactions, from Aug 31, 2024 to May 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mandadi Tilak's filings is in WOONSOCKET, RI.

Recent filings by Mandadi Tilak

May 8, 2026: Open-market sale of CVS shares (Form 4, code S).
Apr 1, 2026: Tax withholding of CVS shares (Form 4, code F).
Mar 31, 2026: Grant or award of CVS shares (Form 4, code A).
Nov 30, 2025: Tax withholding of CVS shares (Form 4, code F).
Aug 31, 2025: Tax withholding of CVS shares (Form 4, code F).

Other insiders filing for CVS HEALTH Corp (CVS)

Clark James David, SVP, Cont & Chief Acct Officer
Newman Brian, EVP, Chief Financial Officer
Compton-Phillips Amy, EVP, Chief Medical Officer
AGUIRRE FERNANDO, Director
ROBBINS LARRY, Director
Gallina John E, Director

How to read Form 4 transaction codes